Fundraising FoxMedic
3 known investors
Find your way into Medic
Sign up to see every warm intro you have to Medic
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Medic team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Medic Life Sciences applies CRISPR functional genomics in 3D patient tumor-like cancer models to identify biomarkers, synthetic lethality, and resistance mutations for oncology drug development. The company focuses on discovering genetic features of cancer with translational relevance for stratifying patients and finding novel drug targets.
Founders & leadership
Investors · 3
Frequently asked questions
- What does Medic do?
- Medic Life Sciences applies CRISPR functional genomics in 3D patient tumor-like cancer models to identify biomarkers, synthetic lethality, and resistance mutations for oncology drug development. The company focuses on discovering genetic features of cancer with translational relevance for stratifying patients and finding novel drug targets.
- Who founded Medic?
- Medic was founded by Kyuho Han, Hong-Pyo Lee.
- Who are Medic's investors?
- Medic's investors include Big Basin Capital, First In Ventures, Sazze.